Literature DB >> 23212406

Brain metabolism changes after therapy with chenodeoxycholic acid in a case of cerebrotendinous xanthomatosis.

Paola Caroppo1, Federico D'Agata, Andrea Mignarri, Maria Laura Stromillo, Maria Teresa Dotti, Tiziana Mongini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23212406     DOI： 10.1007/s10072-012-1262-z

Source DB:  PubMed          Journal:  Neurol Sci        ISSN： 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  4 in total

1.  [Cerebrotendinous xanthomatosis without tendinous xanthomas: presentation of two cases].

Authors:  J Campdelacreu; E Muñoz; A Cervera; S Jaumà; M Girós; E Tolosa
Journal:  Neurologia       Date:  2002-12       Impact factor: 3.109

2.  Magnetic resonance imaging and spectroscopic changes in brains of patients with cerebrotendinous xanthomatosis.

Authors:  N De Stefano; M T Dotti; M Mortilla; A Federico
Journal:  Brain       Date:  2001-01       Impact factor: 13.501

3.  SPECT imaging for brain improvement quantification in a patient with cerebrotendinous xanthomatosis.

Authors:  Albert Selva-O'Callaghan; Ignasi Bardes; Carlos Jacas; Lluis Jubany; Carles Lorenzo-Bosquet; Gemma Cuberas-Borrós; Miquel Vilardell-Tarres
Journal:  Clin Nucl Med       Date:  2011-01       Impact factor: 7.794

4.  Multi-parametric neuroimaging evaluation of cerebrotendinous xanthomatosis and its correlation with neuropsychological presentations.

Authors:  Chiung-Chih Chang; Chun-Chung Lui; Jiun-Jie Wang; Shu-Hua Huang; Cheng-Hsien Lu; Ching Chen; Chih-Feng Chen; Min-Chien Tu; Chi-Wei Huang; Wen-Neng Chang
Journal:  BMC Neurol       Date:  2010-07-06       Impact factor: 2.474
  4 in total
  3 in total

1.  Brain diffusion tensor imaging changes in cerebrotendinous xanthomatosis reversed with treatment.

Authors:  Claudia B Catarino; Christian Vollmar; Clemens Küpper; Klaus Seelos; Constanze Gallenmüller; Joanna Bartkiewicz; Saskia Biskup; Konstanze Hörtnagel; Thomas Klopstock
Journal:  J Neurol       Date:  2017-12-19       Impact factor: 4.849

Review 2.  Cerebrotendinous xanthomatosis: a comprehensive review of pathogenesis, clinical manifestations, diagnosis, and management.

Authors:  Shuke Nie; Guiqin Chen; Xuebing Cao; Yunjian Zhang
Journal:  Orphanet J Rare Dis       Date:  2014-11-26       Impact factor: 4.123

3.  Cerebrotendinous Xanthomatosis: Molecular Pathogenesis, Clinical Spectrum, Diagnosis, and Disease-Modifying Treatments.

Authors:  Shingo Koyama; Yoshiki Sekijima; Masatsune Ogura; Mika Hori; Kota Matsuki; Takashi Miida; Mariko Harada-Shiba
Journal:  J Atheroscler Thromb       Date:  2021-05-08       Impact factor: 4.928
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.